Morbidity and Mortality Weekly Report (MMWR) | MMWR

Morbidity and Mortality Weekly Report (MMWR)

The figure is a photo of a bandage on a person’s arm with text about the latest COVID-19 reports from MMWR.

COVID-19 Reports

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

This figure shows an image of vaccine vials with text describing a new MMWR report on evaluation of COVID-19 vaccine effectiveness.

Continuing Education

The figure is a photo of a parent and child checking in at a COVID-19 vaccination clinic.

Current Weekly

COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022

Also in this issue

Surveillance Summaries

March 11, 2022
Tobacco Product Use and Associated Factors Among Middle and High School Students — National Youth Tobacco Survey, United States, 2021
This report presents 2021 data from the National Youth Tobacco Survey of tobacco product use among U.S. middle school (grades 6–8) and high school (grades 9–12) students.

The figure is a graphic recommending vaccinating children with previous dengue infection living in areas where dengue is endemic.

Recommendations and Reports

December 17, 2021
Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021
ACIP recommends vaccination with Dengvaxia for children aged 9–16 having evidence of previous dengue infection and living in dengue-endemic areas of the U.S.

Supplements

February 25, 2022
Mental Health Surveillance Among Children — United States, 2013–2019
This report summarizes information from nine federal data systems with indicators of children’s mental health during 2013–2019.

Additional Resources

MMWR Visual Abstracts

Page last reviewed: March 11, 2022

Content source: Centers for Disease Control and Prevention